This Android Auto update is trying to change how you drive and use your car
Android Auto is getting a major upgrade that goes beyond design tweaks, bringing smarter navigation, richer entertainment, and a more helpful driving experience.
A study just found brain-eating amoeba in 2 popular U.S. national parks. Here’s what you need to know
Yes, you read that right: Brain-eating amoeba have been found in two popular U.S. national parks, according to a recent study from the U.S. Geological Survey, and a number of other institutions, published in the American Chemical Society’s journal, ES&T Water.
Here’s what to know.
What happened?
Researchers took 185 water samples from five popular U.S. national parks, looking at “40 thermally impacted recreational waters” at Yellowstone National Park, Grand Teton National Park, Lake Mead National Recreation Area, Olympic National Park, and Newberry National Volcanic Monument over an eight year period from 2016 to 2024.
What they found revealed widespread detection of Naegleria fowleri (dubbed “brain-eating amoeba”) in 34% of the samples, or 63 specimens, at Yellowstone, Lake Mead, and Grand Teton hot springs and thermally impacted waters. However, the brain-eating amoeba was not found at Olympic National Park or Newberry National Volcanic Monument.
It’s important to note that no infections or deaths due to the brain-eating amoeba have been reported at the detection sites.
What is Naegleria fowleri?
Naegleria fowleri is a free-living amoeba, a one-celled organism that thrives in warm freshwater lakes, rivers, and hot springs. It’s called the “brain-eating amoeba” because it can infect and destroy brain tissue, according to the Centers for Disease Control and Prevention (CDC).
While brain infections caused by Naegleria fowleri are quite rare, they are nearly always fatal, at a rate of 98%.
If water containing the amoeba goes up a person’s nose into the brain, it can cause an infection called primary amebic meningoencephalitis, or PAM. Typically, fewer than 10 people a year in the U.S. get PAM. However, almost everyone who gets PAM dies from it, per the CDC: Out of 167 reported cases of PAM in the U.S. between 1962 to 2024, only four people survived.
Exposure risks
Brain infections caused by Naegleria fowleri usually occur after a person goes swimming or diving in a lake, river, or other fresh water in the summer after a prolonged period when it was hot, causing higher water temperatures but lower water levels.
The CDC cautions you cannot contract the Naegleria fowleri infection simply by swallowing water containing the amoeba, nor can a person pass it to another person.
How to reduce the risk of contracting a Naegleria fowleri infection
The CDC suggests people hold their nose or wear a nose clip if they are jumping or diving into fresh water, and to keep their head above water in hot springs. Don’t dig in shallow water, because Naegleria fowleri is more likely to live there.
Signs and symptoms of a Naegleria fowleri infection
Primary amebic meningoencephalitis (PAM) progresses quickly, with early symptoms that can include headache, fever, nausea and vomiting, stiff neck, confusion, lack of attention to people and surroundings, loss of balance, and hallucinations.
Most people with PAM die within 18 days after experiencing initial symptoms, with many entering a coma and dying after 5 days, per the CDC.
Bitcoin Clings To $80K As Altcoins Drag Market Lower
Solana, Cardano and Hyperliquid led the day’s losses as risk appetite cooled across digital assets.
Whose art of the deal? Trump & Xi to meet in Beijing
Donald Trump is travelling to Beijing where he will be hosted by Xi Jinping. On the agenda is a series of issues that could cement the superiority of one over the other, and even lead to a new world order. Because beneath the diplomatic and friendly langaage there are messages that will be hard to disgest for someone. Behind the handshake there’s a likely arm wrestle over who has dibs where and when in the world. Our panel will dissect what’s at stake and I hope answer your questions in what is the mopst testing of times.
21Shares Launches First Hyperliquid ETP Alongside 2x Leveraged Fund
- Asset manager 21Shares launched two new Hyperliquid ETPs , providing regulated U.S. investors with exposure to the growing decentralized derivatives sector.
- The Hyperliquid protocol has over 50% of the open interest in the DeFi derivatives sector for perpetual futures, making it a major source of liquidity.
- With intraday sell-off, the Hyperliquid price is nearing a major support retest at $39.
The Hyperliquid price is down 4.75% during Tuesday’s U.S. market hours to trade at $40.07 . This sell-off followed Bitcoin’s 2% drop amid the escalating military tension between the U.S. and Iran and a higher than expected number on U.S. consumer price data for April. Despite the price drop investors, the HYPE coin is poised to witness a surge in institutional Inflows amid two exchanged traded funds, 21shares spot Hyperliquid ETP (THYP) and 21Shares 2x Long Hyperliquid ETF (TXXH).
21Shares Launches Two Nasdaq-Listed Products Tracking Hyperliquid’s HYPE Token
21Shares has launched two new exchange traded products (ETPs) that provide regulated exposure to HYPE, the native token of Hyperliquid, one of the largest decentralised perpetual futures exchanges for trading volume.
The first offering spot Hyperliquid ETP is built on the framework of the 1933 Act. It contains real HYPE tokens and aims to monitor the token’s price in the spot market. Unlike classic 1940 Act ETFs it is not equipped with all the investor protections, including independent board oversight. The sponsor will stake part of the holdings to derive further rewards, but this will have lock up periods, delays in unbonding and risks of forfeiture if a validator underperforms. Custody is provided by reputable providers Anchorage Digital and BitGo, and has a considerable amount of insurance.
The second product, 2x Long Hyperliquid ETF, is a 1940 Act Leveraged Fund that aims to double the daily gain of HYPE using derivatives and daily rebalancing. Like other leveraged products, it’s meant for advanced investors who know about daily resets, compounding and volatility decay. In volatile or sideways markets, returns can deviate from the underlying performance by more than 2x over a longer time horizon — and in extreme cases, the value of the product witnessed significant loss in a single trading session.
| Ticker | ISIN | Exchange | Currency | Fee | Inception | Date Issuer |
| THYP | US90137V1089 | NASDAQ | USD | 0.30% | 4 May 2026 | 21Shares US LLC |
| TXXH | US53656H7364 | NASDAQ | USD | 1.89% | 30 April 2026 | 21Shares US LLC |
Hyperliquid in Focus
Hyperliquid is a purpose-built Layer-1 blockchain designed for high performing trading. It makes orders on-chain through a real-time central limit order book, offering sub-second latency and high throughput, with the ability to report more than 200,000 orders per second maximum. The volumes have been consistently in the billions of dollars daily and over the lifetime of the platform, trillions have been traded. It charges no traditional gas fees for most user interactions.
A substantial share of trading fees — often tens of millions of dollars monthly — is used for open-market HYPE purchases. Most of the tokens are community distributed and team tokens are vested over a timeline that extends through 2028, incentivizing community growth. Hyperliquid has also launched its own virtual machine that will let developers create more DeFi applications that share the same high-performance infrastructure.
“Having pioneered the first Hyperliquid ETP in Europe, we have seen the protocol evolve into a de facto global liquidity hub for decentralized derivatives”, said Andres Valencia, EVP, Investment Management at 21shares.
“We have conviction in the strength of Hyperliquid’s fundamentals and its growing role in decentralized finance – having processed over $4 trillion in cumulative volume since its inception and commanding over 50% of DEX perpetual open interest3. Bringing THYP and TXXH to the U.S. market allows us to bridge the gap for American investors, offering them a transparent way to gain exposure to a network that is demonstrating a high-performance approach to decentralized trading infrastructure.”
The expected distribution date of staking rewards THYP is as below:
| Declaration Date | Ex Date | Record Date | Payable Date |
| 6/26/26 | 6/29/26 | 6/29/26 | 6/30/26 |
| 9/28/26 | 9/29/26 | 9/29/26 | 9/30/26 |
| 12/28/26 | 12/29/26 | 12/29/26 | 12/30/26 |
Key Considerations and Risks in These Hyperliquid ETP
HYPE is still a volatile stock, and the annualised volatility is often well over 100%. The price of it is determined by the trading of perpetuals, network adoption, competition among decentralized and centralized exchanges, and general crypto market sentiment.
They both have high levels of single asset risk. There are staking mechanics risks, custody risks, and leverage risks and path dependency risks for Hyperliquid ETP investors. The fee for the spot product begins at about 0.30% for management fees, and full expense ratios remain to be finalized.
The products will be available for trading on Nasdaq on or around May 12, 2026, after the SEC has reviewed their regulatory filings. The authorizations are responsible for the creation and redemption, and the liquidity of secondary markets relies on market makers and investor demand.
In summary, these launches represent a major milestone in bringing regulated and brokerage-exclusive exposure to one of the most successful trading platforms in DeFi. However, they are not suitable for all investors. Before buyers invest, they need to thoroughly read the prospectus and be aware of the different risks associated with exposure in a physical stake versus a daily leveraged reset.
Hyperliquid Price To Retest Major Channel Support
From its Late-January low of $20.8, the HYPE price has witnessed a steady rally within two parallel trendlines, to currently trade at $40.18, registering a gain of 95.8%. The two trendlines acting as dynamic resistance and support reveals the formation of a classic chart pattern called parallel channel.
With today’s price drop, the coin price is just 3.8% away from the pattern’s bottom trendline at $39. If the support holds, the Hyperliquid HYPE-3.92% price could witness renewed bullish momentum and drive its next recovery leap for above $50.
Despite the Hyperliquid ETP launch, a breakdown below the pattern’s bottom trendline could drive an extended correction towards $30.
Financial Brief: A Weekly Roundup on the Geopolitics of Money | May 12
EXECUTIVE TAKEAWAYS The Pattern: Inflation that was supposed to be temporary is now baked in, China’s playing the long game with resource hoarding, and ethical investing collapses the moment it threatens U.S. political interests. THE RUNDOWN 1. GLOBAL MARKETS AND MOMENTUM U.S. inflation expected to surge to 3.7% as Iran war fuels energy shock U.S. […]
The post Financial Brief: A Weekly Roundup on the Geopolitics of Money | May 12 appeared first on Modern Diplomacy.
Hyperliquid tests KEY support – Can $3.02M whale buy halt HYPE’s decline?
Hyperliquid [HYPE] declined 1.3% over the past 24 hours and was trading at the $41.31 level at press time, marking its second consecutive day of losses. Despite the price dip amid ongoing geopolitical tensions, a crypto whale has shown remarkable interest in the asset by adding millions of dollars’ worth of HYPE tokens. A reportContinue reading “Hyperliquid tests KEY support – Can $3.02M whale buy halt HYPE’s decline?”
Your Android phone is about to get much better at blocking scams
Google has announced a broad set of security upgrades for Android at the Android Show I/O Edition today, headlined by a new verified financial calls feature that will automatically end spoofed calls impersonating your bank.
A growing list of snacks are being recalled over Salmonella fears: Toss these products sold at Target and elsewhere
More than three dozen snack products sold under numerous brand names are being recalled due to fears that one of their ingredients could be contaminated with the potentially deadly bacterium Salmonella. Here’s what you need to know about the snacks recall.
What’s happened?
Beginning last month, a company called California Dairies Inc. recalled buttermilk and bulk powdered milk distributed to manufacturers over fears that the ingredients could be contaminated with Salmonella, according to a safety alert posted by the U.S. Food and Drug Administration (FDA).
Since that initial recall, numerous other brands have recalled their own products that used the recalled ingredients.
Given the potentially deadly nature of Salmonella, the FDA has now compiled all recalled products into a single list to highlight their risk to consumers.
The list of products primarily contains snack items that were sold at various locations across the United States, including one product that was sold in Target stores.
Fast Company has reached out to California Dairies for comment.
What products are included in the recalls?
The number of recalls associated with the original California Dairies now totals eight, according to a May 11 update from the FDA. Those eight recalls include the following:
- Williams Sonoma, Fireworks Popcorn (White Cheddar Seasoning)
- Stoltzfus Family Dairy (Sour Cream and Onion Cheese Curds)
- Wildlife Seasoning (Flavored popcorn seasoning)
- Giant Eagle (Ita Chips with Parmesan, garlic and Herbs)
- Fisher, Southern Style Nuts, Squirrel Brand, Good & Gather (Snack Mixes)
- Pork King Good (Pork rinds and seasoning bottles)
- Zapp’s, Dirty (Potato chips)
- Ghirardelli (Powdered Beverage Mix)
The recalled snack item sold at Target is a Good & Gather Mexican Street Corn Trail Mix product.
What are the symptoms of Salmonella?
Symptoms of a Salmonella infection can vary from individual to individual. According to the U.S. Centers for Disease Control and Prevention (CDC), most people who contract a Salmonella infection present with the following symptoms:
- Watery diarrhea that might have blood or mucus
- Stomach cramps that can be severe
Additionally, some people have other symptoms, including:
- Headache
- Nausea
- Vomiting
- Loss of appetite
Symptoms can start anywhere from 6 hours to 6 days after infection.
The FDA notes that most people will recover from a Salmonella infection without treatment in 4 to 7 days. However, an infection can sometimes be fatal.
Those most at risk include the elderly, children under 5, those who are pregnant, and those with weakened immune systems.
What should I do if I have a recalled product?
Consumers are urged to read the full recall notices to check the items listed against the ones they may have purchased.
Instructions on what to do if you have the recalled items can be found in their individual notices.
These images do not prove that Iran has unveiled kamikaze dolphin drones
Social media users are claiming that the Iranian military has unveiled a new type of kamikaze underwater drone shaped like a dolphin. However, the photos circulating as evidence have been generated by AI.
